Most cited papers from Rheumazentrum Ruhrgebiet

Rheumazentrum Ruhrgebiet

What are the most cited papers from Rheumazentrum Ruhrgebiet?

The most cited paper from Rheumazentrum Ruhrgebiet is "The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection" (Martín Rudwaleit et al., 2009), with 3,707 citations. Next come "Ankylosing spondylitis" (1,824) and "The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis" (1,663).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 274 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection Martín Rudwaleit et al. · Annals of the Rheumatic Diseases Open access	18 Mar 2009	3,707
2	Ankylosing spondylitis Jürgen Braun, Joachim Sieper · The Lancet	Apr 2007	1,824
3	The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis Joachim Sieper, Martín Rudwaleit, Xenofon Baraliakos et al. · Annals of the Rheumatic Diseases	11 May 2009	1,663
4	2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis Désirée M F M van der Heijde et al. · Annals of the Rheumatic Diseases Open access	13 Jan 2017	1,593
5	Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial Jürgen Braun, Jan Brandt, Joachim Listing et al. · The Lancet	Apr 2002	1,265
6	Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis Cédric Lukas, Robert Landewé, Joachim Sieper et al. · Annals of the Rheumatic Diseases	15 Jul 2008	1,073
7	Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis Dominique Baeten, Joachim Sieper, Jürgen Braun et al. · New England Journal of Medicine Open access	23 Dec 2015	1,033
8	ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update Sofía Ramiro et al. · Annals of the Rheumatic Diseases Open access	21 Oct 2022	994
9	2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis Joseph M. Braun et al. · Annals of the Rheumatic Diseases Open access	2 May 2011	987
10	EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update Laure Gossec et al. · Annals of the Rheumatic Diseases Open access	Jun 2020	960
11	The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal Martín Rudwaleit et al. · Annals of the Rheumatic Diseases	19 Mar 2009	950
12	European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update Laure Gossec et al. · Annals of the Rheumatic Diseases Open access	10 Feb 2016	923
13	Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group Martín Rudwaleit, Anne Grethe Jurik, K-G A Hermann et al. · Annals of the Rheumatic Diseases	19 May 2009	897
14	Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial Désirée M F M van der Heijde, Alan Kivitz, Michael H. Schiff et al. · Arthritis & Rheumatism	26 Jun 2006	882
15	Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis Ernst Feldtkeller, Muhammad Arsalan Khan, Désirée M F M van der Heijde et al. · Rheumatology International	Mar 2003	873
16	Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT) Désirée M F M van der Heijde, Ben A. C. Dijkmans, Piet Geusens et al. · Arthritis & Rheumatism	Feb 2005	865
17	2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis Anne-Kathrin Rausch Osthoff et al. · Annals of the Rheumatic Diseases Open access	11 Jul 2018	826
18	Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores Pedro Machado, Robert Landewé, Elisabeth Lie et al. · Annals of the Rheumatic Diseases	11 Nov 2010	805
19	ASAS/EULAR recommendations for the management of ankylosing spondylitis Jane Zochling et al. · Annals of the Rheumatic Diseases Open access	26 Aug 2005	705
20	Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010 Daniel E. Fürst, Edward Clark Keystone, Jürgen Braun et al. · Annals of the Rheumatic Diseases	21 Feb 2011	691
21	Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access	7 Jul 2017	688
22	Ankylosing spondylitis: an overview Joachim Sieper, Jürgen Braun, Martín Rudwaleit et al. · Annals of the Rheumatic Diseases Open access	Nov 2002	667
23	How to diagnose axial spondyloarthritis early Martín Rudwaleit, D van der Heijde, M A Khan et al. · Annals of the Rheumatic Diseases Open access	13 Apr 2004	664
24	ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis Désirée M F M van der Heijde, Elisabeth Lie, Tore Kristian Kvien et al. · Annals of the Rheumatic Diseases	6 Dec 2008	637
25	A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study Won Park, Paweł Hrycaj, Sławomir Jeka et al. · Annals of the Rheumatic Diseases Open access	18 May 2013	607
26	Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial Dominique Baeten et al. · The Lancet	12 Sep 2013	600
27	Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial Robert Davies Inman, John C. Davis, Désirée M F M van der Heijde et al. · Arthritis & Rheumatism	30 Oct 2008	598
28	EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice Péter Mandl et al. · Annals of the Rheumatic Diseases Open access	3 Apr 2015	572
29	Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria Martín Rudwaleit, Anke Metter, Joachim Listing et al. · Arthritis & Rheumatism	30 Jan 2006	552
30	Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group Robert G. Lambert et al. · Annals of the Rheumatic Diseases	15 Jan 2016	545
31	Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis Désirée M F M van der Heijde, Robert Landewé, Xenofon Baraliakos et al. · Arthritis & Rheumatism	29 Sep 2008	519
32	Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study Robert Landewé, Jürgen Braun, Atul A. Deodhar et al. · Annals of the Rheumatic Diseases Open access	6 Sep 2013	476
33	Baseline radiographic damage, elevated acute‐phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis Denis Poddubnyy, Hildrun Haibel, Joachim Listing et al. · Arthritis & Rheumatism	Dec 2011	471
34	Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitis Jan Brandt, Andrei Khariouzov, Joachim Listing et al. · Arthritis & Rheumatism	Jun 2003	469
35	Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access	8 Jun 2013	449
36	European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies Laure Gossec et al. · Annals of the Rheumatic Diseases Open access	28 Sep 2011	448
37	Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept Jürgen Braun, Xenofon Baraliakos, Joachim Listing et al. · Arthritis & Rheumatism	28 Jul 2005	442
38	Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis Martín Rudwaleit, J Listing, J Brandt et al. · Annals of the Rheumatic Diseases Open access	23 Mar 2004	439
39	A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative Laure Gossec et al. · Annals of the Rheumatic Diseases Open access	30 Apr 2014	425
40	International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis Jürgen Braun, T Pham, J Sieper et al. · Annals of the Rheumatic Diseases Open access	15 Aug 2003	425
41	2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis Désirée M F M van der Heijde, Joachim Sieper, Walter P. Maksymowych et al. · Annals of the Rheumatic Diseases	3 May 2011	412
42	New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality Santiago Ewig, Norbert Birkner, Richard S Strauss et al. · Thorax Open access	18 May 2009	412
43	Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system Jürgen Braun, Xenofon Baraliakos, Werner Albert Golder et al. · Arthritis & Rheumatism	Apr 2003	397
44	First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis Jürgen Braun, John C. Davis, Maxime Dougados et al. · Annals of the Rheumatic Diseases Open access	12 Aug 2005	385
45	EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update Laure Gossec et al. · Annals of the Rheumatic Diseases Open access	18 Mar 2024	374
46	Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis Denis Poddubnyy, M. Rudwaleit, Hildrun Haibel et al. · Annals of the Rheumatic Diseases	29 May 2011	357
47	Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six‐month, multicenter, randomized, double‐blind, controlled, phase IV trial Jürgen Braun, Philipp Kastner, P. Flaxenberg et al. · Arthritis & Rheumatism	28 Dec 2007	350
48	Microbial aetiology of community-acquired pneumonia and its relation to severity Catia Cillóniz, Santiago Ewig, Eva Polverino et al. · Thorax Open access	21 Jan 2011	347
49	Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial Iain B. McInnes, Joachim Sieper, Jürgen Braun et al. · Annals of the Rheumatic Diseases	29 Jan 2013	344
50	Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort Denis Poddubnyy, Martín Rudwaleit, Hildrun Haibel et al. · Annals of the Rheumatic Diseases Open access	29 Mar 2012	335

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.